Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan in Lesch-Nyhan Disease
NCT00935753Phase 3Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Apr 2009
- Primary completion
- Feb 2010
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of sapropterin in Lesch-Nyhan syndrome (LNS), sponsored by University of California, San Diego. Planned start Apr 2009; status: withdrawn.
02
Drugs
sapropterin
03
Conditions
Lesch-Nyhan syndrome (LNS)
Beyond the preview
Go deeper on NCT00935753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935753.